(0)サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1501691

経口抗ウイルス剤の世界市場：市場規模 - 適応症別、薬剤クラス別、流通チャネル別、地域別予測（2022～2032年）

Global Oral Antiviral Market Size study, by Indication (Hepatitis, Human Immunodeficiency Virus, Influenza, Others) by Drug Class by Distribution Channel and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.05円
経口抗ウイルス剤の世界市場：市場規模 - 適応症別、薬剤クラス別、流通チャネル別、地域別予測（2022～2032年）
出版日: 2024年06月25日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経口抗ウイルス剤の市場規模は、2023年に約367億米ドルに達し、2024～2032年の予測期間中に2.10％以上の健全な成長率で推移すると予測されています。

経口抗ウイルス剤は口から服用するもので、ウイルス感染と闘う上で極めて重要です。抗ウイルス薬は、ウイルスの複製、宿主細胞への侵入、感染細胞からの放出を阻害することで機能します。これらの薬剤は、インフルエンザ、単純ヘルペスウイルス、B型・C型肝炎、HIVなど、様々なウイルス感染症の最前線の治療薬として機能しています。さらに、特定の状況に合わせて、感染症の予防と治療の両方で重要な役割を果たしています。特にHIVのようなウイルスに感染するリスクが高い人には、予防的に利用されるものもあります。さらに、経口抗ウイルス剤の種類を増やすための研究開発への投資も増加しています。また、より幅広いウイルスをターゲットとした新薬の開発など、経口抗ウイルス剤の世界の市場開拓に向けた投資も活発化しており、注目を集めています。

世界の経口抗ウイルス剤市場は、肝炎、インフルエンザ、HIVなどのウイルス感染症の有病率の上昇に牽引され、効果的な経口抗ウイルス剤への需要が高まっています。この需要は、特に新興市場において、改善されたヘルスケアインフラが利用可能になりつつあることが、さらに拍車をかけています。さらに、経口抗ウイルス剤の製造に向けた医薬品セクターの進歩や技術革新の高まりは、経口抗ウイルス剤市場に有望な機会をもたらしています。さまざまな経口抗ウイルス剤の承認が増加し、世界の主要企業が実施する臨床試験が拡大していることは、市場成長にプラスの影響を与えるものと思われます。しかし、経口抗ウイルス剤には有利な償還政策や副作用がないため、2024～2032年の予測期間中、市場全体の需要を阻害することになるでしょう。

経口抗ウイルス剤の世界市場調査で考慮した主要地域には、アジア太平洋、北米、欧州、ラテンアメリカ、その他の地域が含まれます。2023年、北米は収益面で最大の地域市場でした。HIVやC型肝炎などのウイルス感染の急増と、経口抗ウイルスソリューションを提供する主要プレイヤーの存在、医療インフラの強化が、北米の経口抗ウイルス剤市場の成長を牽引しています。さらに、アジア太平洋地域は、経口抗ウイルス剤開発への投資の増加、ウイルス感染症例の増加、こうした感染症の治療に適したパイプライン医薬品の増加により、最も急速に拡大する見通しです。これらの要因は、2024～2032年の予測期間を通じて、経口抗ウイルス剤市場の成長軌道を後押しします。

目次

第1章 世界の経口抗ウイルス剤市場：定義・調査前提条件

  • 調査目的
  • 市場の定義
  • 調査前提条件
    • 包含と除外
    • 制限事項
    • 供給サイド分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 世界の経口抗ウイルス剤の市場規模・予測（2022～2032年）
  • 地域別概要
  • セグメント別概要
    • 適応症別
    • 薬剤クラス別
    • 流通チャネル別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 世界の経口抗ウイルス剤の市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 世界の経口抗ウイルス剤市場：産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 世界の経口抗ウイルス剤の市場規模・予測：適応症別（2022～2032年）

  • 肝炎
  • ヒト免疫不全ウイルス（HIV）
  • インフルエンザ
  • その他

第6章 世界の経口抗ウイルス剤の市場規模・予測：薬剤クラス別（2022～2032年）

  • プロテアーゼ阻害剤
  • 逆転写酵素阻害薬
  • その他

第7章 世界の経口抗ウイルス剤の市場規模・予測：流通チャネル別（2022～2032年）

  • 病院薬局
  • ドラッグストア・小売薬局
  • オンラインプロバイダー

第8章 世界の経口抗ウイルス剤の市場規模・予測：地域別（2022～2032年）

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ共和国
    • その他の中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Bristol-Myers Squibb Company
      • 主要情報
      • 概要
      • 財務
      • 製品概要
      • 市場戦略
    • Johnson & Johnson Services Inc.
    • AbbVie Inc.
    • Amneal Pharmaceuticals LLC
    • Gilead Sciences, Inc.
    • Viatris Inc.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc

第10章 調査プロセス

  • 調査プロセス
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global Oral Antiviral market, report scope
  • TABLE 2. Global Oral Antiviral market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3. Global Oral Antiviral market estimates & forecasts by Indication 2022-2032 (USD Billion)
  • TABLE 4. Global Oral Antiviral market estimates & forecasts by Drug Class 2022-2032 (USD Billion)
  • TABLE 5. Global Oral Antiviral market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
  • TABLE 6. Global Oral Antiviral market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7. Global Oral Antiviral market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8. Global Oral Antiviral market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9. Global Oral Antiviral market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10. Global Oral Antiviral market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11. Global Oral Antiviral market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12. Global Oral Antiviral market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13. Global Oral Antiviral market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14. Global Oral Antiviral market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15. Global Oral Antiviral market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16. U.S. Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 17. U.S. Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18. U.S. Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 19. Canada Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 20. Canada Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21. Canada Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 22. UK Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 23. UK Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24. UK Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 25. Germany Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 26. Germany Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27. Germany Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 28. France Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 29. France Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30. France Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 31. Italy Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 32. Italy Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33. Italy Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 34. Spain Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 35. Spain Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36. Spain Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 37. RoE Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 38. RoE Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39. RoE Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 40. China Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 41. China Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42. China Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 43. India Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 44. India Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45. India Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 46. Japan Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 47. Japan Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48. Japan Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 49. Australia Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 50. Australia Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51. Australia Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 52. South Korea Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 53. South Korea Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54. South Korea Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 55.
  • TABLE 56. RoAPAC Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 57. RoAPAC Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58. RoAPAC Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 59. Brazil Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 60. Brazil Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61. Brazil Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 62. Mexico Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 63. Mexico Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64. Mexico Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 65. RoLA Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 66. RoLA Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67. RoLA Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 68. Saudi Arabia Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69. Saudi Arabia Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70. Saudi Arabia Oral Antiviral market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 71. South Africa Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 72.
  • TABLE 73. South Africa Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74. South Africa Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75. RoMEA Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76. RoMEA Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77. RoMEA Oral Antiviral market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 78. List of secondary sources, used in the study of Global Oral Antiviral Market.
  • TABLE 79. List of primary sources, used in the study of Global Oral Antiviral Market.
  • TABLE 80. Years considered for the study.
  • TABLE 81. Exchange rates considered.

LIST OF FIGURES

  • FIG 1. Global Oral Antiviral market, research methodology
  • FIG 2. Global Oral Antiviral market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global Oral Antiviral market, key trends 2023
  • FIG 5. Global Oral Antiviral market, growth prospects 2022-2032
  • FIG 6. Global Oral Antiviral market, porters 5 force model
  • FIG 7. Global Oral Antiviral market, pestel analysis
  • FIG 8. Global Oral Antiviral market, value chain analysis
  • FIG 9. Global Oral Antiviral market by segment, 2022 & 2032 (USD Billion)
  • FIG 10. Global Oral Antiviral market by segment, 2022 & 2032 (USD Billion)
  • FIG 11. Global Oral Antiviral market by segment, 2022 & 2032 (USD Billion)
  • FIG 12. Global Oral Antiviral market by segment, 2022 & 2032 (USD Billion)
  • FIG 13. Global Oral Antiviral market by segment, 2022 & 2032 (USD Billion)
  • FIG 14. Global Oral Antiviral market, regional snapshot 2022 & 2032
  • FIG 15. North America Oral Antiviral market 2022 & 2032 (USD Billion)
  • FIG 16. Europe Oral Antiviral market 2022 & 2032 (USD Billion)
  • FIG 17. Asia pacific Oral Antiviral market 2022 & 2032 (USD Billion)
  • FIG 18. Latin America Oral Antiviral market 2022 & 2032 (USD Billion)
  • FIG 19. Middle East & Africa Oral Antiviral market 2022 & 2032 (USD Billion)
  • FIG 20. Global Oral Antiviral market, company market share analysis (2023)
目次

Global Oral Antiviral Market is valued approximately USD 36.7 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 2.10% over the forecast period 2024-2032. Oral antiviral drugs, taken by mouth, are pivotal in combating viral infections. They function by impeding viral replication, entry into host cells, or release from infected cells. These drugs serve as frontline treatments for various viral infections including influenza, herpes simplex virus, hepatitis B and C, HIV, among others. Additionally, they play a crucial role in both preventing and treating infections, tailored to specific circumstances. Some are utilized preventively, particularly for individuals at high risk of contracting viruses such as HIV. Furthermore, rising investing in research and development to expand the range of oral antiviral drugs available. This included developing new drugs targeting a broader spectrum of viruses are gaining attention towards Global Oral Antiviral Market.

The Global Oral Antiviral Market is driven by rising prevalence of viral infections, such as hepatitis, influenza, and HIV, is generating increased demand for effective oral antiviral drugs. This demand is further fueled by the growing availability of improved healthcare infrastructure, particularly in emerging markets. In addition, rising advancements and innovations within the pharmaceutical sector geared towards manufacturing oral antiviral drugs present a promising opportunity for the oral antiviral market. The uptick in approvals for a range of oral antiviral agents, alongside an expanding array of clinical trials conducted by key players worldwide, is poised to positively influence market growth. However, absence of favorable reimbursement policies and side effects of the oral antiviral drugs is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Oral Antiviral market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue. The upsurge in viral infections such as HIV and hepatitis C, coupled with the presence of key players offering oral antiviral solutions and the bolstering of healthcare infrastructure, are driving the of growth in the oral antiviral market in North America. Moreover, the Asia-Pacific region is poised for fastest expansion due to heightened investments in oral antiviral agent development, a rise in cases of viral infections, and an increasing number of pipeline medications tailored for treating such infections. These factors collectively propel the growth trajectory of the oral antiviral market throughout the forecast period 2024-2032.

Major market player included in this report are:

  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services Inc.
  • AbbVie Inc.
  • Amneal Pharmaceuticals LLC
  • Gilead Sciences, Inc.
  • Viatris Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc

The detailed segments and sub-segment of the market are explained below:

By Indication

  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Influenza
  • Others

By Drug Class

  • Protease inhibitors
  • Reverse transcriptase inhibitors
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Drug store and retail pharmacies
  • Online providers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Oral Antiviral Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Oral Antiviral Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Indication
    • 2.3.2. By Drug Class
    • 2.3.3. By Distribution Channel
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Oral Antiviral Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Oral Antiviral Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Oral Antiviral Market Size & Forecasts by Indication 2022-2032

  • 5.1. Hepatitis
  • 5.2. Human Immunodeficiency Virus (HIV)
  • 5.3. Influenza
  • 5.4. Others

Chapter 6. Global Oral Antiviral Market Size & Forecasts by Drug Class 2022-2032

  • 6.1. Protease inhibitors
  • 6.2. Reverse transcriptase inhibitors
  • 6.3. Others

Chapter 7. Global Oral Antiviral Market Size & Forecasts by Distribution Channel 2022-2032

  • 7.1. Hospital pharmacies
  • 7.2. Drug store and retail pharmacies
  • 7.3. Online providers

Chapter 8. Global Oral Antiviral Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Oral Antiviral Market
    • 8.1.1. U.S. Oral Antiviral Market
      • 8.1.1.1. Indication breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Drug Class breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Oral Antiviral Market
  • 8.2. Europe Oral Antiviral Market
    • 8.2.1. U.K. Oral Antiviral Market
    • 8.2.2. Germany Oral Antiviral Market
    • 8.2.3. France Oral Antiviral Market
    • 8.2.4. Spain Oral Antiviral Market
    • 8.2.5. Italy Oral Antiviral Market
    • 8.2.6. Rest of Europe Oral Antiviral Market
  • 8.3. Asia-Pacific Oral Antiviral Market
    • 8.3.1. China Oral Antiviral Market
    • 8.3.2. India Oral Antiviral Market
    • 8.3.3. Japan Oral Antiviral Market
    • 8.3.4. Australia Oral Antiviral Market
    • 8.3.5. South Korea Oral Antiviral Market
    • 8.3.6. Rest of Asia Pacific Oral Antiviral Market
  • 8.4. Latin America Oral Antiviral Market
    • 8.4.1. Brazil Oral Antiviral Market
    • 8.4.2. Mexico Oral Antiviral Market
    • 8.4.3. Rest of Latin America Oral Antiviral Market
  • 8.5. Middle East & Africa Oral Antiviral Market
    • 8.5.1. Saudi Arabia Oral Antiviral Market
    • 8.5.2. South Africa Oral Antiviral Market
    • 8.5.3. Rest of Middle East & Africa Oral Antiviral Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Bristol-Myers Squibb Company
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Johnson & Johnson Services Inc.
    • 9.3.3. AbbVie Inc.
    • 9.3.4. Amneal Pharmaceuticals LLC
    • 9.3.5. Gilead Sciences, Inc.
    • 9.3.6. Viatris Inc.
    • 9.3.7. Merck & Co., Inc.
    • 9.3.8. Teva Pharmaceutical Industries Ltd.
    • 9.3.9. F. Hoffmann-La Roche Ltd
    • 9.3.10. GlaxoSmithKline plc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes